Hospital
Defiance Hospital INC.
Defiance Hospital INC. was paid $11.55M by Medicaid between Jan 2018 and Dec 2024, across 193 billing codes. Its largest line is 99283, emergency room visit (moderate) — 17% of everything it billed.
33Billing provider infoDEFIANCE HOSPITAL INC.
DEFIANCE, OH 43512
DEFIANCE, OH 43512
33aNPI1699775726assigned 07/29/2005
33bProvider typeCritical Access Hospital
28Total paid$11.55M
24GClaims212,082
24DCodes billed193
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Ohio
Rank by total paid#4 of 26
Median peer was paid$5.33M
This provider vs. median2.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13,792 | $664K | |
| 2019 | 10,671 | $512K | |
| 2020 | 11,274 | $675K | |
| 2021 | 14,635 | $890K | |
| 2022 | 16,974 | $1.07M | |
| 2023 | 79,507 | $4.09M | |
| 2024incomplete | 65,229 | $3.65M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 17% | 15,639 | 13,847 | $1.95M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 10% | 8,640 | 7,300 | $1.20M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 9.0% | 8,259 | 7,026 | $1.04M |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 7.1% | 7,719 | 6,594 | $823K |
| 96361 | Intravenous infusion, hydration; each additional hour | 6.3% | 1,838 | 1,092 | $722K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 5.1% | 5,873 | 1,593 | $590K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.2% | 2,293 | 1,776 | $369K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.0% | 5,767 | 4,498 | $345K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2.9% | 2,656 | 1,975 | $338K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.5% | 2,405 | 1,918 | $287K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.5% | 6,690 | 5,313 | $287K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.5% | 843 | 661 | $284K |
181 more codes
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.4% | 1,379 | $273K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.1% | 727 | $247K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1.6% | 2,217 | $186K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.6% | 606 | $185K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.4% | 834 | $166K |
| 59025 | Fetal non-stress test | 1.2% | 886 | $134K |
| 90837 | Psychotherapy session, about an hour | 1.1% | 2,533 | $123K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.0% | 490 | $120K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 1,449 | $113K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 470 | $99K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 465 | $94K |
| 80053 | Comprehensive metabolic panel | <1% | 8,634 | $92K |
| 81514 | <1% | 594 | $92K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 1,706 | $80K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 585 | $65K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 601 | $60K |
| 97162 | <1% | 614 | $55K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,319 | $52K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,889 | $50K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 15,420 | $46K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 325 | $43K |
| G0378 | Hospital observation service, per hour | <1% | 460 | $41K |
| 84439 | <1% | 1,895 | $39K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 13,278 | $37K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,504 | $37K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,297 | $37K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 128 | $35K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,766 | $31K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 929 | $31K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,319 | $29K |
| 85027 | <1% | 2,129 | $24K | |
| 82607 | <1% | 916 | $24K | |
| 76830 | Ultrasound, transvaginal | <1% | 462 | $22K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 479 | $21K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,104 | $21K |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 471 | $21K |
| 80061 | Lipid panel | <1% | 1,332 | $20K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 337 | $20K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 475 | $20K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 763 | $17K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 663 | $16K |
| 84702 | <1% | 598 | $16K | |
| 86850 | <1% | 500 | $15K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 118 | $14K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 289 | $14K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 33 | $13K |
| 86780 | <1% | 503 | $12K | |
| 86140 | <1% | 606 | $12K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 669 | $12K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 182 | $11K |
| 82728 | <1% | 552 | $11K | |
| 74018 | <1% | 281 | $11K | |
| 80076 | <1% | 842 | $10K | |
| 73630 | <1% | 373 | $9K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 45 | $9K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 610 | $9K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 446 | $8K |
| 86900 | <1% | 523 | $8K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 608 | $8K |
| 83540 | <1% | 655 | $7K | |
| 83735 | <1% | 2,630 | $7K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,235 | $7K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 329 | $6K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,749 | $6K |
| 82570 | <1% | 701 | $6K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 334 | $6K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 236 | $6K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,813 | $5K |
| 83550 | <1% | 573 | $5K | |
| 81001 | <1% | 1,091 | $5K | |
| 73610 | <1% | 287 | $5K | |
| 86901 | <1% | 523 | $5K | |
| 64635 | <1% | 28 | $5K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 308 | $5K |
| 76801 | <1% | 31 | $4K | |
| 73562 | <1% | 154 | $4K | |
| 72100 | <1% | 95 | $4K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 86 | $4K |
| 92567 | <1% | 114 | $3K | |
| 84460 | <1% | 469 | $3K | |
| 82746 | <1% | 301 | $3K | |
| 81003 | <1% | 7,186 | $3K | |
| 73030 | <1% | 94 | $3K | |
| 0012A | <1% | 75 | $3K | |
| 94060 | <1% | 16 | $3K | |
| 87660 | <1% | 158 | $3K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 12 | $3K |
| 85652 | <1% | 430 | $3K | |
| 85610 | <1% | 1,222 | $2K | |
| 86803 | <1% | 134 | $2K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 13 | $2K |
| 86787 | <1% | 63 | $2K | |
| 87480 | <1% | 100 | $2K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 125 | $2K |
| 87077 | <1% | 801 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,964 | $2K |
| 87340 | <1% | 91 | $2K | |
| 83970 | <1% | 64 | $2K | |
| 76642 | <1% | 20 | $2K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 54 | $2K |
| 84484 | <1% | 1,694 | $2K | |
| 83880 | <1% | 388 | $2K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 17 | $2K |
| 71250 | <1% | 14 | $2K | |
| 82043 | <1% | 226 | $1K | |
| 82565 | <1% | 151 | $1K | |
| 71045 | Radiologic examination, chest; single view | <1% | 1,113 | $1K |
| 84450 | <1% | 154 | $1K | |
| 97750 | <1% | 17 | $1K | |
| 85379 | <1% | 822 | $1K | |
| 97163 | <1% | 14 | $1K | |
| 87510 | <1% | 100 | $1K | |
| 84156 | <1% | 296 | $1K | |
| 87186 | <1% | 392 | $1K | |
| 94729 | <1% | 16 | $1K | |
| 0011A | <1% | 43 | $1K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 25 | $1K |
| 99221 | <1% | 45 | $1K | |
| 83690 | <1% | 1,741 | $1K | |
| 96376 | <1% | 474 | $965.34 | |
| 73110 | <1% | 31 | $942.67 | |
| 92557 | <1% | 12 | $934.93 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 346 | $910.39 |
| 73130 | <1% | 103 | $884.43 | |
| 84550 | <1% | 198 | $880.33 | |
| 99443 | <1% | 86 | $843.75 | |
| 82950 | <1% | 50 | $777.69 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,515 | $708.27 |
| 86762 | <1% | 35 | $678.52 | |
| 99442 | <1% | 68 | $635.39 | |
| 87150 | <1% | 31 | $594.16 | |
| 85730 | <1% | 561 | $525.71 | |
| 82077 | <1% | 525 | $522.16 | |
| 83615 | <1% | 124 | $493.39 | |
| 0002A | <1% | 12 | $426.24 | |
| 81025 | <1% | 2,385 | $422.20 | |
| 84703 | <1% | 33 | $397.66 | |
| 87081 | <1% | 31 | $392.84 | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 34 | $337.53 |
| 84100 | <1% | 84 | $310.82 | |
| 83605 | <1% | 856 | $286.40 | |
| 87070 | <1% | 79 | $196.07 | |
| 87040 | <1% | 234 | $186.78 | |
| 87205 | <1% | 77 | $115.72 | |
| 82803 | <1% | 33 | $113.05 | |
| 82550 | <1% | 43 | $111.80 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 114 | $103.10 |
| 80047 | <1% | 55 | $83.95 | |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 247 | $78.60 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 722 | $53.57 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 118 | $49.30 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 376 | $44.16 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 31 | $36.61 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 702 | $25.88 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 908 | $25.69 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 18 | $25.20 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 50 | $18.91 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 137 | $18.90 |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | <1% | 25 | $15.80 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 666 | $15.45 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,517 | $15.12 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 491 | $14.74 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 844 | $10.03 |
| J2704 | Injection, propofol, 10 mg | <1% | 553 | $7.20 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 624 | $2.11 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 583 | $1.50 |
| 91301 | <1% | 123 | $1.19 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 68 | $0.47 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 111 | $0.46 |
| 91300 | <1% | 12 | $0.11 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 12 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 65 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 101 | $0.00 |
| C1892 | Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, peel-away | 0% | 46 | $0.00 |
| A9270 | Non-covered item or service | 0% | 57 | $0.00 |
| 87807 | 0% | 30 | $0.00 | |
| 82150 | 0% | 31 | $0.00 | |
| J2060 | Injection, lorazepam, 2 mg | 0% | 14 | $0.00 |
| 94760 | 0% | 14 | $0.00 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 48 | $0.00 |
| J3480 | Injection, potassium chloride, per 2 meq | 0% | 27 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSHARP, KEVIN (VP REV CYCLE)
Parent organizationPROMEDICA HEALTH SYSTEM
| Provider | Location | Paid |
|---|---|---|
| The Toledo Hospital | Toledo, OH | $151.22M |
| Emma L. Bixby Medical Center | Adrian, MI | $18.35M |
| Bay Park Community Hospital | Oregon, OH | $16.39M |
| Community Health Center of Branch County | Coldwater, MI | $11.80M |
| Memorial Hospital | Fremont, OH | $11.40M |
| Fostoria Hospital Association | Fostoria, OH | $7.48M |
| Toledo Hospital | Toledo, OH | $2.38M |
| Herrick Memorial Hospital, INC. | Tecumseh, MI | $1.82M |
| Flower Hospital | Sylvania, OH | $368K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.